Back
Repligen Vs. West Pharmaceutical Services Industry Stock Comparison
Sell
48
RGEN
Repligen
Last Price:
141.70
Seasonality Move:
11.98%
Sell
42
WST
West Pharmaceutical Services
Last Price:
320.95
Seasonality Move:
4.5%
Sell
48
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $141.76. The Score for RGEN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
West Pharmaceutical Services (WST)
is a Sell
Is West Pharmaceutical Services a Buy, Sell or Hold?
- The current West Pharmaceutical Services [WST] share price is $320.88. The Score for WST is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- WST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WST Stock Price Chart
What is West Pharmaceutical Services's stock price today?
-
The West Pharmaceutical Services share price today is $320.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WST is experiencing buying pressure, which is a positive indicator for future bullish movement.
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 52.33 | Buy |
| Chaikin Money Flow: | 577126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (132.45 - 146.27) | Buy |
| Bollinger Bands (100): | (130.51 - 153.71) | Sell |
WST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.25 | Buy |
| Relative Strength Index (14 RSI): | 53.34 | Buy |
| Chaikin Money Flow: | 410752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (299.78 - 329.74) | Buy |
| Bollinger Bands (100): | (293.16 - 320.08) | Buy |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.34 | Buy |
| 20-day SMA: | 138.56 | Buy |
| 50-day SMA: | 140.21 | Buy |
| 200-day SMA: | 156.32 | Sell |
| 8-day EMA: | 136.81 | Buy |
| 20-day EMA: | 138.37 | Buy |
| 50-day EMA: | 140.49 | Buy |
| 200-day EMA: | 150.59 | Sell |
WST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 321.02 | Sell |
| 20-day SMA: | 319.25 | Buy |
| 50-day SMA: | 306.87 | Buy |
| 200-day SMA: | 334.38 | Sell |
| 8-day EMA: | 317.65 | Buy |
| 20-day EMA: | 316.46 | Buy |
| 50-day EMA: | 311.16 | Buy |
| 200-day EMA: | 324.86 | Sell |
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.
West Pharmaceutical Services Earnings Growth & WST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.36 per share, and an increase next year of $0.87 per share.
Repligen Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
West Pharmaceutical Services Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||